Israel
We propel our clients’ success by combining our relationships and experience in the technology and venture capital communities with our insight into the US and Israel tech and financial markets.
Why Cooley
-
Cooley’s Israel market focus supports the prominence of Israeli technology, as well as the dynamic growth of venture capital in Israeli companies and their success in accessing US capital market.
-
We counsel Israeli companies and VCs investing in Israeli enterprises across a wide range of industries, including tech, fintech, cleantech, semiconductors, software, internet infrastructure, Wi-Fi optical networks, wireless communications, pharmaceuticals, biotech and medical devices.
-
We represent global investment banks underwriting securities of Israeli-based companies in US capital markets transactions on Nasdaq and the New York Stock Exchange, including initial public offerings and follow-on offerings.
-
Having worked closely with top Israeli law, accounting and VC firms, we’re deeply familiar with the legal and business opportunities – and challenges – presented by US-Israeli VC, private equity, M&A and capital markets transactions, including tax and intellectual property matters specifically.
Capital Markets Practice Group of the Year
- Law360 (2023, 2019, 2018, 2015)
Cooley handles the lifecycle of emerging companies – it has a genuine focus on startups and early-stage companies, with regular instructions to advise on company formations.
The Legal 500
Global momentum and recognition
- 7,000+ innovative, high-growth private companies as clients
- 1,170+ VC financings annually, with an equal split between investor and company representation
- 1,540+ M&A deals for an aggregate value of more than $745 billion in the past five years
- 1,450+ funds with closings of more than $170 billion committed in the past five years
- #1 law firm in the US and globally for representing companies in VC financing deals (PitchBook, 2023)
- Top 2 law firm for US & global M&A by deal count (Bloomberg, 2023)
- #1 law firm for VC-backed IPOs for 15+ years (IPO Vital Signs, 2023)
- Principal corporate governance and securities counsel for 250+ public companies
- Representing more than 30% of US-based unicorns